Globus Medical, Inc.
GMED
$85.90
-$0.04-0.05%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.74% | 23.49% | 16.65% | 11.75% | 17.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.74% | 23.49% | 16.65% | 11.75% | 17.43% |
| Cost of Revenue | 5.57% | 3.78% | 0.49% | -3.30% | 16.17% |
| Gross Profit | 27.44% | 35.33% | 26.18% | 20.80% | 18.13% |
| SG&A Expenses | 12.97% | 22.11% | 16.13% | 11.73% | 17.27% |
| Depreciation & Amortization | -0.58% | 0.35% | -0.99% | 0.99% | 17.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.63% | 12.11% | 6.68% | 2.17% | 13.55% |
| Operating Income | 81.04% | 96.97% | 83.62% | 86.93% | 44.78% |
| Income Before Tax | 76.72% | 182.67% | 401.21% | 280.43% | 461.28% |
| Income Tax Expenses | 638.19% | 51.45% | 278.85% | 24.33% | -34.73% |
| Earnings from Continuing Operations | 50.13% | 216.18% | 422.28% | 363.08% | 776.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.13% | 216.18% | 422.28% | 363.08% | 776.83% |
| EBIT | 81.04% | 96.97% | 83.62% | 86.93% | 44.78% |
| EBITDA | 49.82% | 57.21% | 51.06% | 48.47% | 33.10% |
| EPS Basic | 51.10% | 219.13% | 425.13% | 364.81% | 775.77% |
| Normalized Basic EPS | 94.78% | 115.11% | 117.20% | 75.71% | 34.26% |
| EPS Diluted | 50.00% | 220.16% | 425.84% | 368.77% | 796.24% |
| Normalized Diluted EPS | 95.13% | 116.38% | 117.33% | 75.00% | 33.16% |
| Average Basic Shares Outstanding | -0.91% | -0.88% | -0.37% | -0.16% | 4.28% |
| Average Diluted Shares Outstanding | -1.17% | -1.42% | -0.34% | 0.36% | 5.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |